Furthermore, the activity of SCD1 also promotes cancer cell proliferation, survival, and invasiveness, partly by altering the lipid domains of the plasma membrane, which favors the activation of tyrosine kinase receptor signaling platforms (Sen et al., 2023; F et al., 2021; D et al., 2022). The gene discussed is SCD; the disease is cancer.